Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.598
https://www.valueinhealthjournal.com/article/S1098-3015(16)31964-7/fulltext
Title :
Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31964-7&doi=10.1016/j.jval.2016.09.598
First page :
A450
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
564